69 related articles for article (PubMed ID: 38474094)
21. 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
Heuser M; Freeman SD; Ossenkoppele GJ; Buccisano F; Hourigan CS; Ngai LL; Tettero JM; Bachas C; Baer C; Béné MC; Bücklein V; Czyz A; Denys B; Dillon R; Feuring-Buske M; Guzman ML; Haferlach T; Han L; Herzig JK; Jorgensen JL; Kern W; Konopleva MY; Lacombe F; Libura M; Majchrzak A; Maurillo L; Ofran Y; Philippe J; Plesa A; Preudhomme C; Ravandi F; Roumier C; Subklewe M; Thol F; van de Loosdrecht AA; van der Reijden BA; Venditti A; Wierzbowska A; Valk PJM; Wood BL; Walter RB; Thiede C; Döhner K; Roboz GJ; Cloos J
Blood; 2021 Dec; 138(26):2753-2767. PubMed ID: 34724563
[TBL] [Abstract][Full Text] [Related]
22. Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy.
Barone SM; Paul AG; Muehling LM; Lannigan JA; Kwok WW; Turner RB; Woodfolk JA; Irish JM
Elife; 2021 Aug; 10():. PubMed ID: 34350827
[TBL] [Abstract][Full Text] [Related]
23. Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancy.
Shameli A; Dharmani-Khan P; Luider J; Auer I; Shabani-Rad MT
Cytometry B Clin Cytom; 2021 Sep; 100(5):574-589. PubMed ID: 33369070
[TBL] [Abstract][Full Text] [Related]
24. Panel Design and Optimization for High-Dimensional Immunophenotyping Assays Using Spectral Flow Cytometry.
Ferrer-Font L; Pellefigues C; Mayer JU; Small SJ; Jaimes MC; Price KM
Curr Protoc Cytom; 2020 Mar; 92(1):e70. PubMed ID: 32150355
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotypic Detection of Measurable Residual (Stem Cell) Disease Using LAIP Approach in Acute Myeloid Leukemia.
Zeijlemaker W; Kelder A; Cloos J; Schuurhuis GJ
Curr Protoc Cytom; 2019 Dec; 91(1):e66. PubMed ID: 31763792
[TBL] [Abstract][Full Text] [Related]
26. An R-Derived FlowSOM Process to Analyze Unsupervised Clustering of Normal and Malignant Human Bone Marrow Classical Flow Cytometry Data.
Lacombe F; Lechevalier N; Vial JP; Béné MC
Cytometry A; 2019 Nov; 95(11):1191-1197. PubMed ID: 31577391
[TBL] [Abstract][Full Text] [Related]
27. Unbiased phenotypic identification of functionally distinct hematopoietic progenitors.
Georgolopoulos G; Iwata M; Psatha N; Yiangou M; Vierstra J
J Biol Res (Thessalon); 2019 Dec; 26():4. PubMed ID: 31360678
[TBL] [Abstract][Full Text] [Related]
28. Use of a Blast Dominance-Hematogone Index for the Flow Cytometric Evaluation of Myelodysplastic Syndrome (MDS).
Schenkel JM; Hergott CB; Dudley G; Drew M; Charest K; Dorfman DM
Am J Clin Pathol; 2019 May; 151(6):584-592. PubMed ID: 30854558
[TBL] [Abstract][Full Text] [Related]
29. Ex Vivo Expansion of Hematopoietic Stem Cells for Therapeutic Purposes: Lessons from Development and the Niche.
Tajer P; Pike-Overzet K; Arias S; Havenga M; Staal FJT
Cells; 2019 Feb; 8(2):. PubMed ID: 30781676
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes.
Ostendorf BN; Flenner E; Flörcken A; Westermann J
PLoS One; 2018; 13(5):e0197823. PubMed ID: 29799854
[TBL] [Abstract][Full Text] [Related]
31. Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.
Schuurhuis GJ; Heuser M; Freeman S; Béné MC; Buccisano F; Cloos J; Grimwade D; Haferlach T; Hills RK; Hourigan CS; Jorgensen JL; Kern W; Lacombe F; Maurillo L; Preudhomme C; van der Reijden BA; Thiede C; Venditti A; Vyas P; Wood BL; Walter RB; Döhner K; Roboz GJ; Ossenkoppele GJ
Blood; 2018 Mar; 131(12):1275-1291. PubMed ID: 29330221
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous measurement of human hematopoietic stem and progenitor cells in blood using multicolor flow cytometry.
Cimato TR; Furlage RL; Conway A; Wallace PK
Cytometry B Clin Cytom; 2016 Sep; 90(5):415-23. PubMed ID: 26663713
[TBL] [Abstract][Full Text] [Related]
33. A simple one-tube assay for immunophenotypical quantification of leukemic stem cells in acute myeloid leukemia.
Zeijlemaker W; Kelder A; Oussoren-Brockhoff YJ; Scholten WJ; Snel AN; Veldhuizen D; Cloos J; Ossenkoppele GJ; Schuurhuis GJ
Leukemia; 2016 Feb; 30(2):439-46. PubMed ID: 26437777
[TBL] [Abstract][Full Text] [Related]
34. FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data.
Van Gassen S; Callebaut B; Van Helden MJ; Lambrecht BN; Demeester P; Dhaene T; Saeys Y
Cytometry A; 2015 Jul; 87(7):636-45. PubMed ID: 25573116
[TBL] [Abstract][Full Text] [Related]
35. Loss of blast heterogeneity in myelodysplastic syndrome and other chronic myeloid neoplasms.
Jevremovic D; Timm MM; Reichard KK; Morice WG; Hanson CA; Viswanatha DS; Howard MT; Nguyen PL
Am J Clin Pathol; 2014 Sep; 142(3):292-8. PubMed ID: 25125617
[TBL] [Abstract][Full Text] [Related]
36. Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations.
Will B; Zhou L; Vogler TO; Ben-Neriah S; Schinke C; Tamari R; Yu Y; Bhagat TD; Bhattacharyya S; Barreyro L; Heuck C; Mo Y; Parekh S; McMahon C; Pellagatti A; Boultwood J; Montagna C; Silverman L; Maciejewski J; Greally JM; Ye BH; List AF; Steidl C; Steidl U; Verma A
Blood; 2012 Sep; 120(10):2076-86. PubMed ID: 22753872
[TBL] [Abstract][Full Text] [Related]
37. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment.
Notta F; Doulatov S; Laurenti E; Poeppl A; Jurisica I; Dick JE
Science; 2011 Jul; 333(6039):218-21. PubMed ID: 21737740
[TBL] [Abstract][Full Text] [Related]
38. Establishment of a normal hematopoietic and leukemia stem cell hierarchy.
Chao MP; Seita J; Weissman IL
Cold Spring Harb Symp Quant Biol; 2008; 73():439-49. PubMed ID: 19022770
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.
Ishikawa F; Yoshida S; Saito Y; Hijikata A; Kitamura H; Tanaka S; Nakamura R; Tanaka T; Tomiyama H; Saito N; Fukata M; Miyamoto T; Lyons B; Ohshima K; Uchida N; Taniguchi S; Ohara O; Akashi K; Harada M; Shultz LD
Nat Biotechnol; 2007 Nov; 25(11):1315-21. PubMed ID: 17952057
[TBL] [Abstract][Full Text] [Related]
40. The leukemic stem cell.
Jordan CT
Best Pract Res Clin Haematol; 2007 Mar; 20(1):13-8. PubMed ID: 17336250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
